Diagnostic Biomarkers and Technology Branch (DBT)

The Diagnostic Biomarkers and Technology Branch stimulates and supports research to develop new biomarkers, diagnostic strategies, innovative technologies and improved devices that will lead to better tools for research and to aid clinical decision-making.

Stimulates and supports research that incorporates new knowledge of cancer biology and tumor-host interactions into cancer diagnosis research.
Stimulates and supports research focused on the development of innovative technologies and devices for use in cancer diagnosis research.
Stimulates and supports research to integrate and apply results from biomarker research and technology development into cancer diagnosis research.

For more information on cancer marker development supported by DBT, please visit Marker Discovery.

For more information on the types of technologies supported by DBT, please visit Technology Development

For information on special funding initiatives and opportunities please visit Obtaining Support for Marker Discovery and Technology Development Projects and Technology Development Initiatives.

For a list of NCI/NIH resources and information of interest to technology developers see Resources and Additional Information for Technology Developers.

If you are a Small Business investigator seeking support for a project, please visit Small Business Funding Opportunities.

DBT Staff:

Name	Title	Phone	Email
James V. Tricoli, PhD	Branch Chief	301-402-4185	tricolij@mail.nih.gov
Miguel Ossandon, MS	Program Director	301-402-4185	ossandom@mail.nih.gov
Brian Sorg, PhD	Program Director	301-402-4185	sorgbs@mail.nih.gov
Tawnya McKee, PhD	Program Director	301-846-1943	mkeeta@mail.nih.gov
Mary Mengesha	Administrative Support	301-496-9019	mengesham@mail.nih.gov

For All CDP Staff